Pfizer slashes stake in COVID vaccine partner BioNTech
(Reuters) -Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE, more than five years after both firms formed an alliance that yielded a vaccine to combat the deadly COVID-19 pandemic. The U.S. drugmaker cut its stake by 54.7%, leaving the company with roughly 1.66 million sponsored American …
Pfizer slashes stake in COVID vaccine partner BioNTech Read More »










